HIV inhibitory activity generated by antigen-stimulated cord blood leukocytes

Circulating SARS-CoV-2 Spike IgG Antibody Levels and Avidity in Autoimmune, IBD and Transplant Cohorts: An Observational Study Following Multiple COVID-19 Vaccine Boosters.

Vaccines·2026

Harmonization of Real-World Data for Vaccine-Preventable Infectious Diseases: Integration of SARS-CoV-2 Diagnostic and Serologic Data From Multiple Sources.

Open forum infectious diseases·2026

A semi-automated ELISA workflow for SARS-CoV-2 Nucleocapsid IgG detection significantly improves throughput and reduces hands-on time.

Journal of immunological methods·2026

Measuring Humoral Immune Responses to SARS-CoV-2: A Comprehensive Review of Serological Assays.

Vaccines·2026

Immune Responses to Human Papillomavirus After Infection and Vaccination.

Current topics in microbiology and immunology·2026

Identifying heart rate characteristics of sleep states of preterm infants using video analysis.

Scientific reports·2026

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

AIDS (London, England)·2026

Efficacy of dolutegravir or bictegravir-containing therapy in a real-life cohort of people with HIV-1 sub-subtype A6.

AIDS (London, England)·2026

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

AIDS (London, England)·2026

Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV.

AIDS (London, England)·2026

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

AIDS (London, England)·2026

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.

AIDS (London, England)·2026

Pre-Pandemic Scientific Insights into Influenza A (H3N2): Viral Evolution, Host Responses, and Evidence-Based Preventive Strategies.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

European journal of pharmacology·2026

Related Experiment Videos

HIV inhibitory activity generated by antigen-stimulated cord blood leukocytes

Related Concept Videos

Circulating SARS-CoV-2 Spike IgG Antibody Levels and Avidity in Autoimmune, IBD and Transplant Cohorts: An Observational Study Following Multiple COVID-19 Vaccine Boosters.

Harmonization of Real-World Data for Vaccine-Preventable Infectious Diseases: Integration of SARS-CoV-2 Diagnostic and Serologic Data From Multiple Sources.

A semi-automated ELISA workflow for SARS-CoV-2 Nucleocapsid IgG detection significantly improves throughput and reduces hands-on time.

Measuring Humoral Immune Responses to SARS-CoV-2: A Comprehensive Review of Serological Assays.

Immune Responses to Human Papillomavirus After Infection and Vaccination.

Identifying heart rate characteristics of sleep states of preterm infants using video analysis.

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

Efficacy of dolutegravir or bictegravir-containing therapy in a real-life cohort of people with HIV-1 sub-subtype A6.

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV.

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.

Pre-Pandemic Scientific Insights into Influenza A (H3N2): Viral Evolution, Host Responses, and Evidence-Based Preventive Strategies.

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

Related Experiment Videos

HIV inhibitory activity generated by antigen-stimulated cord blood leukocytes

Related Concept Videos

Related Articles